66. FIS highlights 2 - Neurosurgical infectio...

BIOCIDES ARE COMING FOR YOU. Find out what they are, what the benefits and harms they have, and what we can do to control their use in consumer products. This was a fascinating, wide-ranging discussion on the use of agents that can affect the human/animal microbiome and environme ...  Show more

Flustered by fluconazole? An ignoramus on itraconazole and isavuconazole?Puzzled by Posa? VEXED BY VORI? Never fear: You can be amazed at the Azoles, just learn how to use 'em right! That's what this episode's all about! Alyssa and Jame UNITE in the first of our episodes on antif ...  Show more

Listener feedback, statin eligibility and Yogi Berra, evidence-based medicine and heterogenous treatment effects, and MRAs in HF are the topics John Mandrola, MD, discusses in this week's podcast.

This podcast is intended for healthcare professionals only.

Inclisiran, sodium-channel blocker safety, analytic flexibility, the work-up of patients with HF, and BP in older patients are the topics John Mandrola, MD, covers in this week's podcast.

This podcast is intended for healthcare professionals only.

To rea ...

Observational studies, another defense of digoxin, CTO-PCI, BP measurement, and a possible revolution in cardiovascular protection are the topics John Mandrola, MD, discusses in this week's podcast.

This podcast is intended for healthcare professionals only. To read a p ...

An update in trial interpretation, CI, and P-values; percutaneous tricuspid Interventions; and news on HDL and humility in Medicine are the topics John Mandrola, MD, covers in this week's podcast.

This podcast is intended for healthcare professionals only</ ...